WO1985002200A1
(en)
*
|
1983-11-14 |
1985-05-23 |
Chiron Corporation |
Interleukin-2 production using cloned genes for interleukin-2 and yeast alpha-factor
|
US5691181A
(en)
*
|
1984-08-21 |
1997-11-25 |
Celltech Limited |
DNA encoding lipase from human gastric mucosal tissue
|
US6808901B1
(en)
*
|
1984-09-03 |
2004-10-26 |
Celltech R&D Limited |
Production of chimeric antibodies
|
GB8422238D0
(en)
*
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
US5853978A
(en)
*
|
1985-12-04 |
1998-12-29 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
|
US6534285B1
(en)
*
|
1984-12-24 |
2003-03-18 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
|
JPS61264000A
(ja)
*
|
1985-03-21 |
1986-11-21 |
イミユネツクス コ−ポレイシヨン |
標識ペプチドによるタンパク質の合成
|
EP0207044A1
(de)
*
|
1985-06-20 |
1986-12-30 |
Monsanto Company |
Freisetzung von Peptiden aus Polypeptiden
|
EP0440311A1
(de)
*
|
1985-06-20 |
1991-08-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Herstellungsverfahren für menschliches alpha-Atrio-natriuretisches Polypeptid
|
US4828799A
(en)
*
|
1985-06-26 |
1989-05-09 |
Research Corporation |
Therapeutic drug monitoring and analyte determination utilizing micellar chromatography
|
FR2594846B1
(fr)
*
|
1986-02-21 |
1989-10-20 |
Genetica |
Procede de preparation de la serum albumine humaine mature
|
SE8601940D0
(sv)
*
|
1986-04-25 |
1986-04-25 |
Kabigen Ab |
Preparation of fused proteins, antibodies and processes therefor
|
US5011912A
(en)
*
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
US4851341A
(en)
*
|
1986-12-19 |
1989-07-25 |
Immunex Corporation |
Immunoaffinity purification system
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
US5215896A
(en)
*
|
1987-03-20 |
1993-06-01 |
Creative Biomolecules, Inc. |
Leader sequences for the production of recombinant proteins
|
US5200509A
(en)
*
|
1987-04-06 |
1993-04-06 |
Celtrix Pharmaceuticals, Inc. |
Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
|
FR2615528B1
(fr)
*
|
1987-05-18 |
1991-05-24 |
Pasteur Institut |
Procede de production d'un polypeptide ayant des proprietes choisies determinees, dans un organisme-hote transforme par un adn recombinant contenant des sequences nucleiques codant pour ce polypeptide et pour une proteine affine d'ose
|
ZA887773B
(en)
|
1987-10-26 |
1989-07-26 |
Immunex Corp |
Interleukin-7
|
ZA888978B
(en)
*
|
1987-12-04 |
1990-07-25 |
Du Pont |
Immobilized interleukin 2 and interleukin 2 containing a carboxylterminal extension
|
US4931498A
(en)
*
|
1988-02-25 |
1990-06-05 |
Purdue Research Foundation |
Immobilized artificial membranes
|
US4927879A
(en)
*
|
1988-02-25 |
1990-05-22 |
Purdue Research Foundation |
Method for solid phase membrane mimetics
|
USRE39760E1
(en)
*
|
1988-03-31 |
2007-08-07 |
International Bio-Immune Systems Inc. |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
|
US5108919A
(en)
*
|
1988-06-24 |
1992-04-28 |
Genentech, Inc. |
Dna sequences encoding yeast ubiquitin hydrolase
|
US5262322A
(en)
*
|
1988-06-24 |
1993-11-16 |
Genentech, Inc. |
Host transformed with yeast gene and ubiquitin/polypeptide fusions
|
US5156968A
(en)
*
|
1988-06-24 |
1992-10-20 |
Genentech, Inc. |
Purified yeast ubiquitin hydrolase
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
ZA902949B
(en)
*
|
1989-05-05 |
1992-02-26 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
DE69019609T2
(de)
*
|
1989-07-07 |
1995-11-30 |
Takeda Chemical Industries Ltd |
Proteine und deren Herstellung.
|
US7413537B2
(en)
*
|
1989-09-01 |
2008-08-19 |
Dyax Corp. |
Directed evolution of disulfide-bonded micro-proteins
|
US5595887A
(en)
*
|
1990-07-16 |
1997-01-21 |
Bionebraska, Inc. |
Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
|
WO1992006191A1
(en)
*
|
1990-09-28 |
1992-04-16 |
Protein Engineering Corporation |
Proteinaceous anti-dental plaque agents
|
JPH07108232B2
(ja)
*
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
US6083686A
(en)
*
|
1990-10-26 |
2000-07-04 |
Johnson & Johnson Clinical Diagnostic Systems, Inc. |
Increased production of Thermus aquaticus DNA polymerase in E. coli
|
CZ109393A3
(en)
*
|
1990-12-13 |
1994-01-19 |
Upjohn Co |
Bonded proteins
|
US5270197A
(en)
*
|
1990-12-20 |
1993-12-14 |
The Children's Medical Center Corporation |
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor
|
ES2287206T3
(es)
*
|
1991-03-01 |
2007-12-16 |
Dyax Corporation |
Proceso para el desarrollo de mini-proteinas de union.
|
ES2123515T3
(es)
|
1991-03-29 |
1999-01-16 |
Immunex Corp |
Antagonistas de citoquinas a base de proteinas virales aisladas.
|
US5852173A
(en)
*
|
1994-10-19 |
1998-12-22 |
Genetics Institute, Inc. |
TNF receptor death ligand proteins and inhibitors of ligand binding
|
US5712381A
(en)
*
|
1994-10-19 |
1998-01-27 |
Genetics Institute, Inc. |
MADD, a TNF receptor death domain ligand protein
|
US5731425A
(en)
*
|
1994-10-28 |
1998-03-24 |
Eastman Kodak Company |
Polypeptide surface marker for cells
|
WO1996017941A2
(en)
*
|
1994-12-07 |
1996-06-13 |
Bionebraska, Inc. |
Production of c-terminal amidated peptides from recombinant protein constructs
|
US5795966A
(en)
|
1995-02-22 |
1998-08-18 |
Immunex Corp |
Antagonists of interleukin-15
|
EP1666591B1
(de)
|
1995-06-29 |
2011-03-23 |
Immunex Corporation |
Cytokin welches Apoptose induziert
|
US5908839A
(en)
|
1995-08-24 |
1999-06-01 |
Magainin Pharmaceuticals, Inc. |
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
|
WO1998028424A2
(en)
|
1996-12-23 |
1998-07-02 |
Immunex Corporation |
Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
|
US6913749B2
(en)
*
|
1998-11-02 |
2005-07-05 |
Resistentia Pharmaceuticals Ab |
Immunogenic polypeptides for inducing anti-self IgE responses
|
WO2002100432A1
(en)
*
|
2001-06-08 |
2002-12-19 |
Genaera Corporation |
Methods for the modulation of il-13
|
WO2000077179A2
(en)
|
1999-06-16 |
2000-12-21 |
Icos Corporation |
Human poly(adp-ribose) polymerase 2 materials and methods
|
US6379903B1
(en)
*
|
1999-10-08 |
2002-04-30 |
Sigma-Aldrich Co. |
Purification of recombinant proteins fused to multiple epitopes
|
WO2001068674A2
(en)
*
|
2000-03-13 |
2001-09-20 |
Monsanto Technology Llc |
Preparation of recombinant proteins containing repeating units
|
AU5566701A
(en)
|
2000-04-25 |
2001-11-07 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
EP1939203B1
(de)
|
2000-04-25 |
2014-11-19 |
ICOS Corporation |
Hemmer der delta-Isoform der menschlichen Phosphatidyl-Inositol-3-Kinase
|
DE60138922D1
(de)
*
|
2000-10-10 |
2009-07-16 |
Univ Oklahoma |
Vergleichende ligandenabbildung aus mhc-positiven zellen
|
US6756215B1
(en)
|
2000-10-20 |
2004-06-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Functionalized TGF-β fusion proteins
|
ZA200305980B
(en)
|
2001-02-12 |
2007-01-31 |
Res Dev Foundation |
Modified proteins, designer toxins, and methods of making thereof
|
DE10112851C1
(de)
*
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
CA2442935A1
(en)
|
2001-04-05 |
2002-10-17 |
The Board Of Regents Of The University Of Nebraska |
Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
|
CN1555268B
(zh)
|
2001-07-17 |
2013-04-03 |
研究发展基金会 |
含促调亡蛋白质的治疗剂
|
US8088602B1
(en)
|
2001-12-05 |
2012-01-03 |
Elizabeth Gay Frayne |
Manipulation of RNA stability and protein synthesis using thio-phosphate
|
WO2003074676A2
(en)
|
2002-03-01 |
2003-09-12 |
Monsanto Technology Llc |
Wax ester synthase dna sequence, protein and uses thereof
|
US7799561B2
(en)
*
|
2002-06-12 |
2010-09-21 |
Sigma-Aldrich, Co. |
Affinity peptides and method for purification of recombinant proteins
|
CN1695058B
(zh)
|
2002-09-09 |
2011-04-13 |
生命树股份有限公司 |
诊断宫颈癌的方法
|
AU2003270619A1
(en)
*
|
2002-09-12 |
2004-04-30 |
Molecular Probes, Inc. |
Site-specific labeling of affinity tags in fusion proteins
|
JP4773947B2
(ja)
*
|
2003-01-09 |
2011-09-14 |
マクロジェニクス,インコーポレーテッド |
細菌細胞及び哺乳動物細胞における抗体発現のための二重発現ベクター系
|
US20040259162A1
(en)
*
|
2003-05-02 |
2004-12-23 |
Sigma-Aldrich Co. |
Solid phase cell lysis and capture platform
|
ES2383328T3
(es)
|
2003-07-25 |
2012-06-20 |
Amgen, Inc |
Métodos relacionados con LDCAM y CRTAM
|
US20050178959A1
(en)
*
|
2004-02-18 |
2005-08-18 |
Viorica Lopez-Avila |
Methods and compositions for assessing a sample by maldi mass spectrometry
|
EP1761540B1
(de)
|
2004-05-13 |
2016-09-28 |
Icos Corporation |
Chinazolinone als inhibitoren der humanen phosphatidylinosit-3-kinase delta
|
WO2006026248A1
(en)
|
2004-08-25 |
2006-03-09 |
Sigma-Aldrich Co. |
Compositions and methods employing zwitterionic detergent combinations
|
US7741053B2
(en)
*
|
2005-05-13 |
2010-06-22 |
Sigma-Aldrich Co. |
Processes for purification of recombinant proteins
|
WO2006138700A2
(en)
*
|
2005-06-17 |
2006-12-28 |
Biorexis Pharmaceutical Corporation |
Anchored transferrin fusion protein libraries
|
US20070275416A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh |
Affinity marker for purification of proteins
|
EP1878744A1
(de)
*
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-Tag für an der Oberfläche exprimierte T-Zell Rezeptor Proteine, deren Anwendung und Verfahren zur Selection von Wirtszellen, die sie exprimieren
|
EP2061887B1
(de)
*
|
2006-10-04 |
2018-01-24 |
The University Of Queensland |
Zuführungssystem für impfstoff gegen grippe auf vlp-basis
|
CA2666415C
(en)
|
2006-10-11 |
2012-11-27 |
Oriental Yeast Co., Ltd. |
Agent containing fused protein of soluble rankl with epitope tag
|
US20080118524A1
(en)
*
|
2006-10-20 |
2008-05-22 |
Stefan Persson |
Anti-IgE Vaccines
|
KR20090098880A
(ko)
|
2006-12-12 |
2009-09-17 |
바이오렉시스 파마슈티칼 코포레이션 |
트랜스페린 융합 단백질 라이브러리
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
EP2142217B1
(de)
*
|
2007-03-27 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
Verfahren zum nachweis von automatisch aufbereitetem sezerniertem pcsk9
|
US7897369B2
(en)
*
|
2007-08-27 |
2011-03-01 |
Regents Of The University Of Minnesota |
Isoprenoid wax ester synthases, isoprenoid acyl CoA-synthetases, and uses thereof
|
WO2009064802A2
(en)
*
|
2007-11-13 |
2009-05-22 |
Eli Lilly & Co. |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US20110129857A1
(en)
*
|
2009-11-27 |
2011-06-02 |
Msdx, Inc. |
Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition
|
WO2009075798A2
(en)
*
|
2007-12-05 |
2009-06-18 |
University Of Georgia Research Foundation, Inc. |
Hydrogenase polypeptide and methods of use
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
RU2530555C2
(ru)
|
2008-04-17 |
2014-10-10 |
ПиДиЭс БАЙОТЕКНОЛОДЖИ КОРПОРЭЙШН |
Стимуляция иммунного ответа энантиомерами катионных липидов
|
US8546553B2
(en)
|
2008-07-25 |
2013-10-01 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic RNAi-like system and methods of use
|
CA2737544A1
(en)
|
2008-09-18 |
2010-03-25 |
University Of Georgia Research Foundation, Inc. |
Methods and compositions for degrading pectin
|
WO2010054108A2
(en)
*
|
2008-11-06 |
2010-05-14 |
University Of Georgia Research Foundation, Inc. |
Cas6 polypeptides and methods of use
|
CN102272153B
(zh)
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
WO2010089412A1
(en)
|
2009-02-09 |
2010-08-12 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof
|
EP2258719A1
(de)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Mehrfachziel-T-Zellen-Rezeptor
|
CN102482329B
(zh)
|
2009-07-24 |
2017-11-14 |
免疫设计公司 |
用辛德毕斯病毒包膜糖蛋白假型化的慢病毒载体
|
EA201792376A3
(ru)
|
2009-10-23 |
2018-08-31 |
Милленниум Фармасьютикалз, Инк. |
Молекулы анти-gcc антитела и соответствующие композиции и способы
|
US8911743B2
(en)
|
2009-11-04 |
2014-12-16 |
Regents Of The University Of Minnesota |
Haemophilus parasuis polypeptides and methods of use
|
CN102762565A
(zh)
|
2010-02-22 |
2012-10-31 |
弗·哈夫曼-拉罗切有限公司 |
吡啶并[3,2-d]嘧啶PI3δ抑制剂化合物及使用方法
|
US8734780B2
(en)
|
2010-06-04 |
2014-05-27 |
Medtronic, Inc. |
Methods for treating cardiac pacing conditions
|
KR101531117B1
(ko)
|
2010-07-14 |
2015-06-23 |
에프. 호프만-라 로슈 아게 |
Pi3k p110 델타에 대해 선택적인 퓨린 화합물, 및 사용 방법
|
WO2012019061A2
(en)
|
2010-08-05 |
2012-02-09 |
Stem Centrx, Inc. |
Novel effectors and methods of use
|
KR20140018837A
(ko)
|
2010-08-27 |
2014-02-13 |
스템 센트알엑스 인코포레이티드 |
노텀 단백질 조절 인자 및 사용 방법
|
US9458231B2
(en)
|
2010-09-03 |
2016-10-04 |
Stemcentrx, Inc. |
Modulators and methods of use
|
AU2011295722B2
(en)
|
2010-09-03 |
2016-04-21 |
Abbvie Stemcentrx Llc |
Identification and enrichment of cell subpopulations
|
WO2013119964A2
(en)
|
2012-02-08 |
2013-08-15 |
Stem Centrx, Inc. |
Identification and enrichment of cell subpopulations
|
TWI585106B
(zh)
|
2010-12-08 |
2017-06-01 |
艾伯維史坦森特瑞斯有限責任公司 |
新穎調節劑及其使用方法
|
US9339526B2
(en)
|
2011-01-17 |
2016-05-17 |
University Of Manitoba |
Methods for treating disorders that involve immunoglobulin A
|
US8673309B2
(en)
*
|
2011-02-11 |
2014-03-18 |
Msdx, Inc. |
Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
|
EP2675473A1
(de)
|
2011-02-15 |
2013-12-25 |
Immune Design Corp. |
Verfahren zur verbesserung von immunogenspezifischen immunreaktionen durch vektorisierte impfstoffe
|
SA112330278B1
(ar)
|
2011-02-18 |
2015-10-09 |
ستيم سينتركس، انك. |
مواد ضابطة جديدة وطرق للاستخدام
|
US9244073B2
(en)
|
2011-02-25 |
2016-01-26 |
Wellstat Diagnostics, Llc |
Assays for detecting enzymatic activity
|
MX350795B
(es)
|
2011-04-08 |
2017-09-19 |
Inmune Design Corp |
Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
EP2817338B1
(de)
|
2012-02-24 |
2017-07-26 |
AbbVie Stemcentrx LLC |
Dll3-modulatoren und verwendungsverfahren
|
MX360245B
(es)
|
2012-03-09 |
2018-10-26 |
Csl Behring Ag |
Composiciones que comprenden inmunoglobulinas de tipo secretor.
|
HUE034593T2
(en)
|
2012-03-28 |
2018-02-28 |
Univ Texas |
TGF II-III. types of receptor fusions
|
ES2707288T3
(es)
|
2012-03-30 |
2019-04-03 |
Immune Design Corp |
Partículas de vectores lentivíricos que tienen eficiencia de transducción mejorada para células que expresan DC-SIGN
|
WO2014039879A1
(en)
|
2012-09-06 |
2014-03-13 |
North Carolina State University |
Sequestration of carbon dioxide with hydrogen to useful products
|
AU2013317805B2
(en)
|
2012-09-21 |
2018-07-26 |
Pds Biotechnology Corporation |
Improved vaccine compositions and methods of use
|
US10036047B2
(en)
|
2013-06-10 |
2018-07-31 |
University Of Georgia Research Foundation, Inc. |
Methods for hydroxylating phenylpropanoids
|
US9353390B2
(en)
|
2013-06-13 |
2016-05-31 |
University Of Georgia Research Foundation, Inc. |
Genetically engineered microbes and methods for producing 4-hydroxycoumarin
|
JP6599861B2
(ja)
|
2013-08-07 |
2019-10-30 |
リグスホスピタレット コペンハーゲン ユニバーシティ ホスピタル |
男性不妊治療用の抗体、化合物、およびその誘導体
|
CA2922547C
(en)
|
2013-08-28 |
2020-03-10 |
Stemcentrx, Inc. |
Site-specific antibody conjugation methods and compositions
|
WO2015031541A1
(en)
|
2013-08-28 |
2015-03-05 |
Stem Centrx, Inc. |
Novel sez6 modulators and methods of use
|
AU2015218365A1
(en)
|
2014-02-14 |
2016-09-01 |
Immune Design Corp. |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
EP3134439B1
(de)
|
2014-04-21 |
2018-12-26 |
Millennium Pharmaceuticals, Inc. |
Anti-psyk-antikörpermoleküle und verwendung davon für eine auf syk abzielende therapie
|
MA51688A
(fr)
|
2014-05-26 |
2020-12-02 |
Academisch Ziekenhuis Leiden |
Protéines prohémostatiques pour le traitement de saignement
|
EP3169352A1
(de)
|
2014-07-15 |
2017-05-24 |
Immune Design Corp. |
Prime-boost-therapieschemata mit einem tlr4-agonist-adjuvans und einem lentivirusvektor
|
EP3012269A1
(de)
|
2014-10-20 |
2016-04-27 |
Erhard Hofer |
Zytokin-ähnliches 1 (CYTL1)-Protein und Verwendungen davon
|
DK3244911T3
(da)
|
2015-01-12 |
2019-12-16 |
Rigshospitalet Copenhagen Univ Hospital |
Fremgangsmåde til bestemmelse af en sandsynlig virkning af en behandling til forbedring af mandlig ufrugtbarhed
|
IL282614B2
(en)
|
2015-02-06 |
2024-02-01 |
Cell Idx Inc |
Antigen-conjugated immune reagents
|
CA2981509A1
(en)
|
2015-03-30 |
2016-10-06 |
The Board Of Regents Of The Nevada System Of Higher Educ. On Behalf Of The University Of Nevada, La |
Compositions comprising talens and methods of treating hiv
|
CN107750163A
(zh)
|
2015-05-29 |
2018-03-02 |
犹他大学研究基金会 |
免疫耐受性和非免疫耐受性弹性蛋白样重组肽及使用方法
|
US10858760B2
(en)
|
2015-06-01 |
2020-12-08 |
Medigene Immunotherapies Gmbh |
T cell receptor library
|
NZ737423A
(en)
|
2015-06-01 |
2019-08-30 |
Medigene Immunotherapies Gmbh |
Method for generating antibodies against t cell receptor
|
CN108350037A
(zh)
|
2015-11-09 |
2018-07-31 |
免疫设计股份有限公司 |
包含表达il-12的慢病毒载体的组合物及其使用方法
|
AU2016354102B2
(en)
|
2015-11-09 |
2022-05-12 |
Immune Design Corp. |
A retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
|
EP3374496A4
(de)
|
2015-11-13 |
2019-07-10 |
PDS Biotechnology Corporation |
Lipide als synthetische vektoren zur verbesserung der antigenverarbeitung und präsentation ex-vivo in der dendritischen zelltherapie
|
KR20180089439A
(ko)
|
2015-11-25 |
2018-08-08 |
아카데미슈 지켄후이스 라이덴 |
재조합 세린 프로테아제
|
US10882891B2
(en)
|
2015-12-23 |
2021-01-05 |
Medigene Immunotherapies Gmbh |
Dendritic cell composition
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
WO2017180998A2
(en)
|
2016-04-15 |
2017-10-19 |
Beckman Coulter, Inc. |
Photoactive macromolecules and uses thereof
|
UA127310C2
(uk)
|
2016-05-16 |
2023-07-19 |
Презідент Енд Феллоуз Оф Гарвард Колледж |
Спосіб очищення і активації ботулінічного нейротоксину
|
WO2018026283A1
(en)
|
2016-08-04 |
2018-02-08 |
Stichting Vumc |
Embryonic angiogenesis markers and diagnostic and therapeutic strategies based thereon
|
KR20230119735A
(ko)
|
2017-02-12 |
2023-08-16 |
바이오엔테크 유에스 인크. |
Hla 기반 방법 및 조성물, 및 이들의 용도
|
EP3668309A4
(de)
|
2017-08-14 |
2021-06-09 |
University of Georgia Research Foundation, Inc. |
Proteine mit pneumokokken-kapsel-abbauender aktivität und verwendungsverfahren
|
US11198722B2
(en)
|
2017-10-06 |
2021-12-14 |
University Of Utah Research Foundation |
Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
|
CA3090917A1
(en)
|
2018-02-26 |
2019-08-29 |
Medigene Immunotherapies Gmbh |
Nyeso tcr
|
EP3806888B1
(de)
|
2018-06-12 |
2024-01-31 |
Obsidian Therapeutics, Inc. |
Von pde5 abgeleitete regulatorische konstrukte und verfahren zur verwendung in der immuntherapie
|
JP7174144B2
(ja)
|
2018-08-06 |
2022-11-17 |
メディジーン イミュノテラピーズ ゲーエムベーハー |
Ha-1特異的t細胞受容体およびその使用
|
WO2020070089A1
(en)
|
2018-10-01 |
2020-04-09 |
Ospedale San Raffaele S.R.L. |
Chromogranin a and uses thereof
|
WO2020086742A1
(en)
|
2018-10-24 |
2020-04-30 |
Obsidian Therapeutics, Inc. |
Er tunable protein regulation
|
BR102019025989A2
(pt)
|
2018-12-14 |
2020-06-23 |
Beckman Coulter, Inc. |
Modificação de corantes poliméricos e aplicações
|
WO2020132586A1
(en)
|
2018-12-21 |
2020-06-25 |
Neon Therapeutics, Inc. |
Method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ t cells
|
KR20210149251A
(ko)
|
2019-03-08 |
2021-12-08 |
옵시디안 테라퓨틱스, 인크. |
조율가능한 조절을 위한 인간 탄산 무수화효소 2 조성물 및 방법
|
EP3714941A1
(de)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4-tcrs
|
TW202102530A
(zh)
|
2019-04-04 |
2021-01-16 |
德商梅迪基因免疫治療公司 |
黑色素瘤相關抗原1(magea1)特異性t細胞受體及其用途
|
EP3983537A1
(de)
|
2019-06-12 |
2022-04-20 |
Obsidian Therapeutics, Inc. |
Ca2-zusammensetzungen und verfahren zur abstimmbaren regulierung
|
MX2021015097A
(es)
|
2019-06-12 |
2022-04-01 |
Obsidian Therapeutics Inc |
Composiciones de ca2 y metodos para regulación ajustable.
|
KR20220052910A
(ko)
|
2019-07-09 |
2022-04-28 |
메디진 이뮤노테라피스 게엠바하 |
Magea10 특이적 t 세포 수용체 및 이의 용도
|
US20220348937A1
(en)
|
2019-09-06 |
2022-11-03 |
Obsidian Therapeutics, Inc. |
Compositions and methods for dhfr tunable protein regulation
|
WO2021067741A1
(en)
|
2019-10-02 |
2021-04-08 |
University Of Georgia Research Foundation, Inc. |
Glycopeptides for inducing an immune response and methods of use
|
US20230211004A1
(en)
|
2019-11-22 |
2023-07-06 |
University Of Georgia Research Foundation, Inc. |
Tetanus toxoid and crm-based peptides and methods of use
|
WO2021118976A1
(en)
|
2019-12-09 |
2021-06-17 |
University Of Georgia Research Foundation, Inc. |
M. tuberculosis ag85 proteins and methods of use
|
US20230285519A1
(en)
|
2020-07-17 |
2023-09-14 |
University Of Georgia Research Foundation, Inc. |
B-glucuronidase proteins having pneumococcal capsule degrading activity and methods of use
|
AU2021347595A1
(en)
|
2020-09-24 |
2023-05-04 |
Medigene Immunotherapies Gmbh |
Mage-a3 specific t cell receptors and their use
|
EP4288776A1
(de)
|
2021-02-05 |
2023-12-13 |
Beckman Coulter, Inc. |
Zusammensetzungen und verfahren zur verhinderung von nichtspezifischen wechselwirkungen zwischen polymerfarbstoff-antikörper-konjugaten
|
AU2022270947A1
(en)
|
2021-05-07 |
2023-11-16 |
Medigene Immunotherapies Gmbh |
Combination of prame specific t cell receptors and chimeric co-stimulatory receptors
|
WO2023025779A1
(en)
|
2021-08-25 |
2023-03-02 |
Medigene Immunotherapies Gmbh |
Combination of antigen specific t cell receptors and chimeric co-stimulatory receptors
|
WO2023056460A1
(en)
|
2021-09-30 |
2023-04-06 |
Beckman Coulter, Inc. |
Water-soluble tetrahydropyrene based fluorescent polymers
|
WO2024041761A1
(en)
|
2022-08-23 |
2024-02-29 |
Medigene Immunotherapies Gmbh |
Combination of ny-eso-1 specific t cell receptors and chimeric co-stimulatory receptors
|